JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB181250

Anti-CSGALNACT2 antibody [EPR13670]

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal CSGALNACT2 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.

View Alternative Names

CHGN2, GALNACT2, PRO0082, CSGALNACT2, Chondroitin sulfate N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2

1 Images
Western blot - Anti-CSGALNACT2 antibody [EPR13670] (AB181250)
  • WB

Supplier Data

Western blot - Anti-CSGALNACT2 antibody [EPR13670] (AB181250)

All lanes:

Western blot - Anti-CSGALNACT2 antibody [EPR13670] (ab181250) at 1/10000 dilution

Lane 1:

293 cell lysate at 20 µg

Lane 2:

Jurkat cell lysate at 20 µg

Lane 3:

K562 cell lysate at 20 µg

Lane 4:

Raji cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 63 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13670

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Complementary Products

Primary Antibodies

AB224611

Anti-Mannosidase II/MAN2A1 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Mannosidase II/MAN2A1 antibody (AB224611)

  • 0
  • 0
Primary Antibodies

AB174280

Anti-TGN46 antibody [EPR12676] - Golgi Marker

20ul selling size|RabMAb|Recombinant|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TGN46 antibody [EPR12676] - Golgi Marker (AB174280)

  • 0
  • 0
Primary Antibodies

AB52649

Anti-GM130 antibody [EP892Y] - cis-Golgi Marker

RabMAb|Recombinant|Lab Essentials|20ul selling size

Immunoprecipitation - Anti-GM130 antibody [EP892Y] - cis-Golgi Marker (AB52649)

  • 5
  • 39
Primary Antibodies

AB37266

Anti-Giantin antibody [9B6] - Golgi Marker

Lab Essentials

Immunocytochemistry/ Immunofluorescence - Anti-Giantin antibody [9B6] - Golgi Marker (AB37266)

  • 4
  • 15
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.
See full target information CSGALNACT2
style
left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Cellular oncology (Dordrecht, Netherlands) 47:897-915 PubMed38082211

2023

CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1.

Applications

Unspecified application

Species

Unspecified reactive species

Mingjun Ma,Chao Wang,Meixuan Wu,Sijia Gu,Jiani Yang,Yue Zhang,Shanshan Cheng,Shilin Xu,Minghai Zhang,Yongsong Wu,Yaqian Zhao,Xiu Tian,Dominic Chih-Cheng Voon,Chiaki Takahashi,Jindan Sheng,Yu Wang

Alcoholism, clinical and experimental research 46:556-569 PubMed35187673

2022

Gag-like proteins: Novel mediators of prenatal alcohol exposure in neural development.

Applications

Unspecified application

Species

Unspecified reactive species

Marisa R Pinson,Dae D Chung,Amanda H Mahnke,Nihal A Salem,Daniel Osorio,Vijay Nair,Elizabeth A Payne,Jonathan J Del Real,James J Cai,Rajesh C Miranda
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com